Patients’ knowledge of their medication is essential to the physician’s decision making process. Despite this, studies demonstrate a lack of patient knowledge regarding the medications they take.  The proposed study is correlational and descriptive in nature and aims to assess the patients’ knowledge of their medication when presenting to the Emergency Department (ED) and the Family Medicine clinics in the American University of Beirut Medical Center. A convenient sample of patients presenting to the ER will be surveyed after consent is obtained. The patients will be approached when their health status has been stabilized and during their result waiting times as determined appropriate by treating physician. The health care needs will take the priority over the data collection process.  Participants must be above 18 years of age and the expected number of participants is 152. The questionnaire will assess the patient’s knowledge of their own medication through questions on the dosage, purpose, timing of administration, possible side effects, interactions and foods to be avoided for each medication.

A convenient sample of patients presenting to the ER will be surveyed after consent is obtained. The patients will be approached when their health status has been stabilized and during their result waiting times as determined appropriate by treating physician.Participants must be above 18 years of age and the expected number of participants is 152. 

Participants who consent will be asked the questions of the survey. Potential participants will be approached after it has been determined that they are able to participate. Informed consent is explained by the research assistant, if approval is given, questions of the survey, expected to take 10 minutes, will be read out, and their answers will be filled out by the research assistant. Participants will be assured that refusal to participate will have no negative consequences on them and will not affect them in any way. Confidentiality and anonymity is emphasized and ensured. The data collected will be locked in the PI’s office for a period of three years, after which they will be discarded. There are no expected risks associated with the study.